Aminopeptidases in visceral organs during alterations in body fluid volume and osmolality

Peptides

Volumn 24, Issue 9, 2003, Pages 1367-1372

  Gasparello Clemente, Elaine ^a   Casis, Luis ^b   Varona, Adolfo ^b   Gil, Javier ^b   Irazusta, Jon ^b   Silveira, Paulo Flávio ^a  

^a INSTITUTO BUTANTAN   (Brazil)

^b UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

Hydrosaline challenges; Osmoregulation; Peptidases; Volemia; Water electrolyte homeostasis

Indexed keywords

5 OXOPROLYL PEPTIDASE; AMINOPEPTIDASE; PEPTIDE;

ADRENAL GLAND; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY FLUID; CONTROLLED STUDY; ENZYME ACTIVITY; HYPEROSMOLALITY; HYPOVOLEMIA; KIDNEY MEDULLA; MALE; NONHUMAN; OSMOLALITY; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT; REGULATORY MECHANISM; TISSUE DISTRIBUTION; VISCERA;

EID: 0347990379     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2003.08.006     Document Type: Article

References (38)

1. Alfie M.E., Sigmon D.H., Pomposiello S.I., Carretero O.A. Effect of high salt intake in mutant mice lacking bradykinin-B2 receptors. Hypertension. 29:1997;483-487.
2. Beers MH, Berkow R, editors. Water, electrolyte, mineral, and acid-base metabolism. In: The Merck manual of diagnosis and therapy, Internet edition, chapter 12, section 2: endocrine and metabolic disorders. Medical Services, USMEDSA, USHH, 1999.
3. Bergmeyer HU, Brent E. Assay with pyruvate and NADH. In: Methods in enzymatic analysis. Academic Press Inc., London, vol. 2, 1972: 574-577.
4. Bernton E.W., Long J.B., Holaday J.W. Opioids and neuropeptides: mechanisms in circulatory shock. Fed. Proc. 44:1985;290-299.
5. Bouloux P.M., Corsello S., Besser M., Grossman A. The acute cardiovascular actions of intravenous thyrotrophin releasing hormone (TRH) in man are mediated by non-catecholaminergic mechanisms. Br. J. Clin. Pharmacol. 42:1996;225-232.
6. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
7. Cheung H.S., Cushman D.W. A soluble aspartate aminopeptidase from dog kidney. Biochim. Biophys. Acta. 242:1971;190-193.
8. Cummins P.M., O'Connor B. Pyroglutamyl peptidase: an overview of the three known enzymatic forms. Biochim. Biophys. Acta. 1429:1998;1-17.
9. Feuerstein G., Zukowska-Grojec Z., Bayorh M., Kopin I.J., Faden A.I. Leukotriene D4-induced hypotension is reversed by thyrotropin-releasing hormone. Prostaglandins. 26:1983;711-724.
10. Frohman L.A. CNS peptides and glucoregulation. Annu. Rev. Physiol. 45:1983;95-107.
11. -14 mol. Biochem. Biophys. Res. Commun. 9:1962;430-435.
12. Gupta N., Garg U.C., Dhand R., Kaur A., Ganguly N.K. Enzyme levels in bronchoalveolar lavage fluid and serum of active pulmonary tuberculosis patients. Enzyme. 41:1989;108-111.
13. Halperin M.L., Kamel K.S. Dynamic interactions between integrative physiology and molecular medicine: the key to understand the mechanism of action of aldosterone in the kidney. Can. J. Physiol. Pharmacol. 78:2000;587-594.
14. Hayashi M.A.F., Murbach A.F., Ianzer D., Portaro F.C.V., Prezoto B.C., Fernandes B.L.et al. The C-type natriuretic peptide precursor of snake brain contains highly specific inhibitors of the angiotensin-converting enzyme. J. Neurochem. 85:2003;969-977.
15. Healy D.P., Song L.J. Kidney aminopeptidase A and hypertension, part I - spontaneously hypertensive rats. Hypertension. 33:1999;740-745.
16. Irazusta J., Silveira P.F., Gil J., Varona A., Casis L. Effects of hydrosaline treatments on prolyl endopeptidase activity in rat tissues. Regul. Pept. 101:2001;141-147.
17. Juillerat-Jeanneret L. Modulation of proteolytic activity in tissues following chronic inhibition of angiotensin-converting enzyme. Biochem. Pharmacol. 45:1993;1447-1454.
18. Katori M., Majima M., Hayashi I. Crucial suppressive role of renal kallikrein-kinin system in development of salt-sensitive hypertension. Biol. Res. 31:1998;143-149.
19. Kokkonen J.O., Kuoppala A., Saarinen J., Lindstedt K.A., Kovanen P.T. Kallidin- and bradykinin-degrading pathways in human heart: degradation of kallidin by aminopeptidase M-like activity and bradykinin by neutral endopeptidase. Circulation. 20:1999;1984-1990.
20. Kugler P. Aminopeptidase A is angiotensinase A. II. Biochemical studies on aminopeptidase A and M in rat kidney homogenate. Histochemistry. 74:1982;247-261.
21. Mantle D. Comparison of soluble aminopeptidases in human cerebral cortex, skeletal muscle and kidney tissues. Clin. Chim. Acta. 207:1992;107-118.
22. Mattson D.L., Wu F. Control of arterial blood pressure and renal sodium excretion by nitric oxide synthase in the renal medulla. Acta Physiol. Scand. 168:2000;149-154.
23. Meng Q.C., Durand J., Chen Y.F., Oparil S. Effects of dietary salt on angiotensin peptides in kidney. J. Am. Soc. Nephrol. 6:1995;1209-1215.
24. Mizutani S., Goto K., Nomura S., Ino K., Goto S., Kikkawa F.et al. Possible action of human placental aminopeptidase N in feto-placental unit. Res. Commun. Chemical Pathol. Pharmacol. 82:1993;65-80.
25. Prasad C. Limited proteolysis and physiological regulation: an example from thyrotropin-releasing hormone metabolism. Thyroid. 8:1998;969-975.
26. Ramírez-Expósito M.J., Martínez J.M., Prieto I., Alba F., Ramírez M. Comparative distribution of glutamyl and aspartyl aminopeptidase activities in mouse organs. Horm. Metab. Res. 32:2000;161-163.
27. Schwabe C., McDonald J.K. Demonstration of a pyroglutamyl residue at the N terminus of the B-chain of porcine relaxin. Biochem. Biophys. Res. Commun. 74:1977;1501-1504.
28. Silveira P.F., Irazusta J., Gil J., Agirregoitia N., Casis L. Interactions among challenges of hydromineral balance, angiotensin-converting enzyme, and cystine aminopeptidase. Peptides. 22:2001;2137-2144.
29. Silveira P.F., Schiripa L.N., Picarelli Z.P. Hydrolysis of L-cystine-di-β-naphthylamide and neurohypophyseal peptides by the plasma of the snake Bothrops jararaca. Comp. Biochem. Physiol. B. 102:1992;119-122.
30. Song L.J., Healy D.P. Kidney aminopeptidase A and hypertension, part II: effects of angiotensin II. Hypertension. 33:1999;746-752.
31. Strabak V. Heart - the source and target of "hypothalamic neurohormones": do they provide a delicate regulation complementary to the conduction system in the heart? Gen. Physiol. Biophys. 19:2000;341-343.
32. Tagliavini S., Bazzani C., Bertolini E., Bertolini A., Guarini S. TRH reverses the ECG and EEG ischemic changes induced by massive hemorrhage in rats. Life Sci. 49:1991;1815-1821.
33. Varona A., Silveira P.F., Irazusta A., Valdivia A., Gil J. Effects of changes of hydromineral balance on rat brain aspartyl, arginyl and alanyl aminopeptidase activities. Horm. Metab. Res. 35:2003;36-42.
34. Waldegger S., Busch G.L., Kaba N.K., Zempel G., Ling H., Heidland A.et al. Effect of cellular hydration on protein metabolism. Miner. Electrolyte Metabol. 23:1977;201-205.
35. Watson J.E. Fluid and electrolyte disorders in cardiovascular patients. Nursing Clin. North Am. 22:1987;797-803.
36. Xu Y., Wellner D., Scheinberg D.A. Substance P and bradykinin are natural inhibitors of CD13/aminopeptidase N. Biochem. Biophys. Res. Commun. 208:1995;664-674.
37. Yayoi Y., Ohsawa Y., Koike M., Zhang G., Kominami E., Uchiyama Y. Specific localization of lysosomal aminopeptidases in type II alveolar epithelial cells of the rat lung. Arch. Histol. Cytol. 64:2001;89-97.
38. Zheng D., Chen H.S., Hu D.Y. Cardiovascular mechanisms of thyrotropin-releasing hormone against experimental hemorrhagic shock. Circulatory Shock. 36:1992;169-173.